Skip to content

Descriptive Study of Acute Spontaneous Spinal Cord Infarction

Descriptive Study of Acute Spontaneous Spinal Cord Infarction : EDMIAS

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04372758
Acronym
EDMIAS
Enrollment
60
Registered
2020-05-04
Start date
2020-05-30
Completion date
2021-01-01
Last updated
2021-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Infarction, Spinal Cord Stroke, Vascular Myelopathy

Keywords

Neurology, Vascular disease, Paraplegia, Quadriplegia

Brief summary

Acute spontaneous Spinal Cord Infarctions (SCI) are an uncommon cause of myelopathy (5%), but their prognostic is heterogeneous and frequently severe. Positive diagnosis is difficult, one quarter of initial MRIs are normal. Differential diagnosis with other transverse myelopathy causes is a common issue. As in cerebral stroke, there are multiple causes and mechanisms in spontaneous SCI, often difficult to clearly establish. There are also clinical and radiological patterns, sometimes misleading, according to vascular territory and its expanse. Due to its scarcity and heterogeneity, improving knowledge and medical care remains difficult. Medical care is still badly codified in medical literature. Recently, diagnostic criteria have been proposed to better identify SCI, provide earlier care and homogenize future research. External validity and reproduction of these new criteria among acute myelopathies are still to be validated. While there is no established medical treatment in the initial care of spontaneous SCI, some case reports show successful treatment with IV thrombolysis. Given the severe prognosis, conventional treatment of strokes (thrombolysis, anticoagulant and antiplatelet), could be considered on an individual scale, in a specific protocol. A better knowledge of radio-clinical and security factors are necessary to support this approach. In order to respond to these difficulties, a retrospective cohort will allow us to better define epidemiological, clinico-radiological and prognostic features of spontaneous SCI. It lays the foundation of a possible prospective multicentric cohort, necessary for specific therapeutic studies.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Nīmes
CollaboratorOTHER
University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hospitalized patients in a medical ward in Montpellier and Nîmes University Hospitals with registered diagnosis of vascular myelopathy * And final diagnosis of spontaneous SCI after reviewing medical datas

Exclusion criteria

* non ischemic myelopathies : compression, hematomyelia, spinal DAVF, intramedullary tumor, inflammatory, infectious or post-infectious myelitis, post-radiation myelopathy,…) * secondary SCI : SCI following an aortic, cardiac or rachidian surgery, extracorporeal circulation, post-hemodynamic shock * SCI without a cause

Design outcomes

Primary

MeasureTime frameDescription
description of a recent spontaneous SCI cohort10 yearsNumber of patients hospitalized for spontaneous SCI in the last 10 years in Montpellier and Nîmes University Hospital

Secondary

MeasureTime frameDescription
evaluation of JAMA 2019 diagnostic criteria in spontaneous SCI and other myelopathies1 dayevaluation of JAMA 2019 diagnostic criteria in spontaneous SCI and other myelopathies
analysis of relevant clinical and radiological criteria for positive diagnosis and prognosis1 dayanalysis of relevant clinical and radiological criteria for positive diagnosis and prognosis
Description of clinico-radiological territories, etiology and physiopathology of spontaneous SCI, including application of fibrocartilaginous embolism criteria 20151 dayDescription of clinico-radiological territories, etiology and physiopathology of spontaneous SCI, including application of fibrocartilaginous embolism criteria 2015
Retrospective evaluation of the potential candidates for IV thrombolysis1 dayRetrospective evaluation of the potential candidates for IV thrombolysis
Evaluation of relevant criteria in order to create a prospective multicentric cohort of spontaneous SCI.1 dayEvaluation of relevant criteria in order to create a prospective multicentric cohort of spontaneous SCI.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026